Department of Cardiology, RWTH Aachen University, Aachen, Germany,
Clin Res Cardiol. 2015 Mar;104(3):258-71. doi: 10.1007/s00392-014-0780-5. Epub 2014 Nov 1.
The present prospective study investigated whether a combined approach integrating two different stress imaging modalities may improve the diagnostic accuracy and prognostic impact of non-invasive coronary artery disease (CAD) tests in postmenopausal women. In women non-invasive tests for detecting CAD are less accurate than in men, leading to a high proportion of unnecessary coronary angiographies (CAs).
424 consecutive postmenopausal women (mean 61 ± 7 years, mean Reynolds Risk Score 13 ± 3 %) with symptoms suggestive of CAD were prospectively included and followed up for 4 ± 1 years. Each patient underwent CA, stress cardiovascular magnetic resonance (CMR) by adenosine, dobutamine stress echocardiography (DSE) and single-photon emission computed tomography (SPECT) within 7 ± 3 days.
Anatomically obstructive coronary artery disease (≥50 % diameter stenosis) was present in 157 women (37 %). The combination of two stress imaging modalities significantly increased the positive predictive values (PPV) to 90 ± 3, 88 ± 3 and 87 ± 2 % for CMR/DSE, DSE/SPECT and CMR/SPECT, respectively. For patients with negative combined test results, the survival analysis showed a 4-year cumulative event-free survival rate of 96-97 % for all combinations. This new approach is cost effective due to the resulting reduction in unnecessary CAs (with potential side effects and corresponding therapies) as well as reducing hospitalization time.
In symptomatic postmenopausal women, combination of two negative stress imaging results significantly increases the PPV for detection of CAD and excludes future cardiovascular events with high accuracy. This approach may be applied to improve the prognostic precision of non-invasive CAD tests and to avoid unnecessary CAs.
本前瞻性研究旨在探讨整合两种不同应激成像方式的联合方法是否可以提高绝经后女性非侵入性冠状动脉疾病(CAD)检测的诊断准确性和预后影响。对于女性而言,非侵入性 CAD 检测的准确性低于男性,这导致了大量不必要的冠状动脉造影(CA)。
424 例连续绝经后女性(平均年龄 61±7 岁,平均雷诺风险评分 13±3%)有 CAD 症状,前瞻性纳入并随访 4±1 年。每位患者在 7±3 天内行 CA、腺苷应激心脏磁共振(CMR)、多巴酚丁胺负荷超声心动图(DSE)和单光子发射计算机断层扫描(SPECT)检查。
157 例女性(37%)存在解剖学上的阻塞性 CAD(≥50%的直径狭窄)。两种应激成像方式的联合显著提高了 CMR/DSE、DSE/SPECT 和 CMR/SPECT 的阳性预测值(PPV),分别为 90±3%、88±3%和 87±2%。对于联合检测结果为阴性的患者,生存分析显示,所有组合的 4 年累积无事件生存率为 96-97%。由于减少了不必要的 CA(可能存在副作用和相应的治疗)以及缩短了住院时间,这种新方法具有成本效益。
在有症状的绝经后女性中,两种阴性应激成像结果的联合显著提高了 CAD 的阳性预测值,并以高准确度排除了未来的心血管事件。这种方法可以应用于提高非侵入性 CAD 检测的预后准确性,并避免不必要的 CA。